Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Cristina Pirosa"'
Autor:
Giuseppe A. Palumbo, Stefania Stella, Maria Stella Pennisi, Cristina Pirosa, Elisa Fermo, Sonia Fabris, Daniele Cattaneo, Alessandra Iurlo
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
The hallmark of BCR-ABL1-negative myeloproliferative neoplasms (MPNs) is the presence of a driver mutation in JAK2, CALR, or MPL gene. These genetic alterations represent a key feature, useful for diagnostic, prognostic and therapeutical approaches.
Externí odkaz:
https://doaj.org/article/2b7c577213dd4d8dbd6fd4e543daff1f
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTPatients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) require additional treatments, especially those not eligible or not responding to high dose cytotoxic chemotherapy and stem cell transplantation. Over the last f
Externí odkaz:
https://doaj.org/article/67c75f5223d94dd089953e5ef432e992
Autor:
Anastasios Stathis, Maria Cristina Pirosa, Lorella Orsucci, Pierre Feugier, Monica Tani, Hervé Ghesquières, Gerardo Musuraca, Francesca Gaia Rossi, Francesco Merli, Romain Guièze, Emmanuel Gyan, Guido Gini, Dario Marino, Remy Gressin, Franck Morschhauser, Federica Cavallo, Francesca Palombi, Annarita Conconi, Benoît Tessoulin, Hervé Tilly, Manuela Zanni, Maria Giuseppina Cabras, Enrico Capochiani, Catello Califano, Melania Celli, Alessandro Pulsoni, Francesco Angrilli, Ubaldo Occhini, René-Olivier Casasnovas, Guillaume Cartron, Liliana Devizzi, Corinne Haioun, Anna Marina Liberati, Roch Houot, Michele Merli, Giuseppe Pietrantuono, Francesca Re, Michele Spina, Francesco Landi, Franco Cavalli, Francesco Bertoni, Davide Rossi, Nicoletta Ielmini, Elena Borgo, Stefano Luminari, Emanuele Zucca, Catherine Thieblemont
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The IELSG38 trial was conducted to investigate the effects of subcutaneous (SC) rituximab on the complete remission (CR) rate and the benefits of SC maintenance in patients with extranodal marginal zone lymphoma (MZL) who received frontline treatment
Externí odkaz:
https://doaj.org/article/ca0b0cb56ee341db9e250e5812bdbf1f
Autor:
Maria Cristina Pirosa, Marianna Sassone, Barbara Kiesewetter, Armando Lopez Guillermo, Liliana Devizzi, Eva Domingo Domènech, Alessandra Tucci, Donato Mannina, Michele Merli, Antonio Salar, Carlo Visco, Fabiana Esposito, Luisella Bonomini, Emanuele Zucca, Andrés J. M. Ferreri, Markus Raderer
Publikováno v:
Haematologica, Vol 108, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/cb75afc21020422d8c0086e48da6fc8f
Publikováno v:
HemaSphere, Vol 6, Iss 6, p e727 (2022)
The rapid evolution of genomic technologies over the last years has led to the development of different methods for the detection, measurement and analysis of cell-free DNA fragments (cfDNA) which are shed into the bloodstream by apoptotic cells and
Externí odkaz:
https://doaj.org/article/f227bce9f75b443c8a315d4a1cd9dc7a
Publikováno v:
Human Vaccines & Immunotherapeutics; 2024, Vol. 20 Issue 1, p1-7, 7p
Publikováno v:
Current Opinion in Oncology. 34:454-463
PURPOSE The first convincing evidence for a causal relationship between bacterial infection and lymphomagenesis came from the link between gastric lymphoma and chronic Helicobacter pylori gastritis. This review will summarize the current epidemiologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8027e9379895146dffb276fe29523a
https://doi.org/10.1097/cco.0000000000000886
https://doi.org/10.1097/cco.0000000000000886
Autor:
Michael Schaffer, Valeria Spina, Maria Cristina Pirosa, Ricardo Koch, Sriram Balasubramanian, Bernhard Gerber, Gabriela Forestieri, Alessio Bruscaggin, Brendan P. Hodkinson, Lodovico Terzi di Bergamo, M. Faderl, Nele Fourneau, John Alvarez, Wei Wu, Georg Stussi, Ferdinando Bonfiglio, Davide Rossi, Adalgisa Condoluci, Emanuele Zucca
Publikováno v:
Blood Advances
Key Points ctDNA technology is useful for noninvasive monitoring of lymphoma treated with targeted agents in the clinical trial setting.An early >2-log reduction of ctDNA levels after 2 treatment cycles was a confirmed threshold for molecular respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce84f267180c9c14eae2b49b02dda782
https://doi.org/10.1182/bloodadvances.2021004528
https://doi.org/10.1182/bloodadvances.2021004528
Autor:
Uros Markovic, Ernesto Vigna, Francesco Grimaldi, Giulia Palazzo, Antonio M. Risitano, Massimo Martino, Maria Cristina Pirosa, Giuseppe Milone, Stefania Stella, Giovanni Pisapia, Angelo Curto Pelle, Raffaele Palmieri, Luca Scalise, Francesco Di Raimondo, Stefania Tringali, Salvatore Leotta, Giulio Antonio Milone, Valerio Leotta, Fausto Palmieri, Paola Carluccio, Mary Ann Di Giorgio, Giorgina Specchia, Anna Bulla, Mario Annunziata
Publikováno v:
Annals of Hematology. 100:1743-1753
The experience of third-generation tyrosine kinase inhibitor ponatinib treatment in Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph'+ ALL) patients post-allogeneic transplantation is limited. We retrospectively collected data on 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be11aca1edce41136532ac07b6144fc
https://doi.org/10.1007/s00277-021-04504-0
https://doi.org/10.1007/s00277-021-04504-0
Autor:
Lodovico Terzi di Bergamo, Maria Cristina Pirosa, Alessio Bruscaggin, Matin Salehi, Valeria Spina, Katia Pini, Simone Bocchetta, Claudia Giordano, Adalgisa Condouci, Gabriela Forestieri, Deborah Piffaretti, Joyce Marques de Almeida, Salvatore Annunziata, Fabrizio Bergesio, Eugenio Borsatti, Pietro Bulian, Stephane Chauvie, Marco Cuzzocrea, Martina Di Trani, Bernhard Gerber, Michal Kurlapski, Alden Moccia, Riccardo Moia, Andrea Rinaldi, Marcello Rodari, Grzegorz Romanowicz, Gian Mauro Sacchetti, Alessandra Stasia, Anastasios Stathis, Georg Stuessi, Ilaria Zangrilli, Luigi Maria Larocca, Antonello Pinto, Armando Santoro, Franco Cavalli, Emanuele Zucca, Valter Gattei, Jan Maciej Zaucha, Carmelo Carlo Stella, Stefan Hohaus, Gianluca Gaidano, Luca Ceriani, Davide Rossi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S348-S349
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8cbb89d905d2731ea060fde6c18b1d3
https://doi.org/10.1016/s2152-2650(22)01480-x
https://doi.org/10.1016/s2152-2650(22)01480-x